Literature DB >> 19546216

Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation.

A Kathrin Lutz1, Nicole Exner, Mareike E Fett, Julia S Schlehe, Karina Kloos, Kerstin Lämmermann, Bettina Brunner, Annerose Kurz-Drexler, Frank Vogel, Andreas S Reichert, Lena Bouman, Daniela Vogt-Weisenhorn, Wolfgang Wurst, Jörg Tatzelt, Christian Haass, Konstanze F Winklhofer.   

Abstract

Loss-of-function mutations in the parkin gene (PARK2) and PINK1 gene (PARK6) are associated with autosomal recessive parkinsonism. PINK1 deficiency was recently linked to mitochondrial pathology in human cells and Drosophila melanogaster, which can be rescued by parkin, suggesting that both genes play a role in maintaining mitochondrial integrity. Here we demonstrate that an acute down-regulation of parkin in human SH-SY5Y cells severely affects mitochondrial morphology and function, a phenotype comparable with that induced by PINK1 deficiency. Alterations in both mitochondrial morphology and ATP production caused by either parkin or PINK1 loss of function could be rescued by the mitochondrial fusion proteins Mfn2 and OPA1 or by a dominant negative mutant of the fission protein Drp1. Both parkin and PINK1 were able to suppress mitochondrial fragmentation induced by Drp1. Moreover, in Drp1-deficient cells the parkin/PINK1 knockdown phenotype did not occur, indicating that mitochondrial alterations observed in parkin- or PINK1-deficient cells are associated with an increase in mitochondrial fission. Notably, mitochondrial fragmentation is an early phenomenon upon PINK1/parkin silencing that also occurs in primary mouse neurons and Drosophila S2 cells. We propose that the discrepant findings in adult flies can be explained by the time of phenotype analysis and suggest that in mammals different strategies may have evolved to cope with dysfunctional mitochondria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19546216      PMCID: PMC2755701          DOI: 10.1074/jbc.M109.035774

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death.

Authors:  Frédéric Darios; Olga Corti; Christoph B Lücking; Cornelia Hampe; Marie-Paule Muriel; Nacer Abbas; Wen-Jie Gu; Etienne C Hirsch; Thomas Rooney; Merle Ruberg; Alexis Brice
Journal:  Hum Mol Genet       Date:  2003-03-01       Impact factor: 6.150

2.  Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission.

Authors:  Zdena Harder; Rodolfo Zunino; Heidi McBride
Journal:  Curr Biol       Date:  2004-02-17       Impact factor: 10.834

3.  Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein.

Authors:  Nathan C Shaner; Robert E Campbell; Paul A Steinbach; Ben N G Giepmans; Amy E Palmer; Roger Y Tsien
Journal:  Nat Biotechnol       Date:  2004-11-21       Impact factor: 54.908

4.  Inactivation of parkin by oxidative stress and C-terminal truncations: a protective role of molecular chaperones.

Authors:  Konstanze F Winklhofer; Iris H Henn; Penelope C Kay-Jackson; Ulrich Heller; Jörg Tatzelt
Journal:  J Biol Chem       Date:  2003-09-12       Impact factor: 5.157

5.  Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila.

Authors:  Yufeng Yang; Isao Nishimura; Yuzuru Imai; Ryosuke Takahashi; Bingwei Lu
Journal:  Neuron       Date:  2003-03-27       Impact factor: 17.173

6.  Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants.

Authors:  Jessica C Greene; Alexander J Whitworth; Isabella Kuo; Laurie A Andrews; Mel B Feany; Leo J Pallanck
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

7.  Cre-lox-regulated conditional RNA interference from transgenes.

Authors:  Andrea Ventura; Alexander Meissner; Christopher P Dillon; Michael McManus; Phillip A Sharp; Luk Van Parijs; Rudolf Jaenisch; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

8.  Alterations in the common fragile site gene Parkin in ovarian and other cancers.

Authors:  Stacy R Denison; Fang Wang; Nicole A Becker; Birgitt Schüle; Norman Kock; Leslie A Phillips; Christine Klein; David I Smith
Journal:  Oncogene       Date:  2003-11-13       Impact factor: 9.867

9.  Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking.

Authors:  Andreas Weihofen; Kelly Jean Thomas; Beth L Ostaszewski; Mark R Cookson; Dennis J Selkoe
Journal:  Biochemistry       Date:  2009-03-10       Impact factor: 3.162

10.  In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice.

Authors:  A Consiglio; A Quattrini; S Martino; J C Bensadoun; D Dolcetta; A Trojani; G Benaglia; S Marchesini; V Cestari; A Oliverio; C Bordignon; L Naldini
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

View more
  179 in total

Review 1.  The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease.

Authors:  Victor S Van Laar; Sarah B Berman
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

Review 2.  Mechanisms of mitochondria and autophagy crosstalk.

Authors:  Angelika S Rambold; Jennifer Lippincott-Schwartz
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

Review 3.  Cell signaling and mitochondrial dynamics: Implications for neuronal function and neurodegenerative disease.

Authors:  Theodore J Wilson; Andrew M Slupe; Stefan Strack
Journal:  Neurobiol Dis       Date:  2012-01-24       Impact factor: 5.996

Review 4.  Regulation of Parkin E3 ubiquitin ligase activity.

Authors:  Helen Walden; R Julio Martinez-Torres
Journal:  Cell Mol Life Sci       Date:  2012-04-19       Impact factor: 9.261

Review 5.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

Review 6.  Parkinson's disease: insights from pathways.

Authors:  Mark R Cookson; Oliver Bandmann
Journal:  Hum Mol Genet       Date:  2010-04-26       Impact factor: 6.150

Review 7.  S-nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegeneration.

Authors:  Tomohiro Nakamura; Piotr Cieplak; Dong-Hyung Cho; Adam Godzik; Stuart A Lipton
Journal:  Mitochondrion       Date:  2010-05-04       Impact factor: 4.160

Review 8.  Missing pieces in the Parkinson's disease puzzle.

Authors:  Jose A Obeso; Maria C Rodriguez-Oroz; Christopher G Goetz; Concepcion Marin; Jeffrey H Kordower; Manuel Rodriguez; Etienne C Hirsch; Matthew Farrer; Anthony H V Schapira; Glenda Halliday
Journal:  Nat Med       Date:  2010-05-23       Impact factor: 53.440

9.  Collapsin response mediator protein 5 (CRMP5) induces mitophagy, thereby regulating mitochondrion numbers in dendrites.

Authors:  Sébastien Brot; Carole Auger; Rabia Bentata; Véronique Rogemond; Stéphane Ménigoz; Naura Chounlamountri; Agnès Girard-Egrot; Jérôme Honnorat; Mahnaz Moradi-Améli
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

10.  Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects.

Authors:  Asad A Aboud; Andrew M Tidball; Kevin K Kumar; M Diana Neely; Kevin C Ess; Keith M Erikson; Aaron B Bowman
Journal:  Neurotoxicology       Date:  2012-10-22       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.